These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17645464)

  • 1. Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease.
    Farhadi A; Keshavarzian A; Fields JZ; Jakate S; Shaikh M; Banan A
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2338-43. PubMed ID: 17645464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heightened responses to stressors in patients with inflammatory bowel disease.
    Farhadi A; Keshavarzian A; Van de Kar LD; Jakate S; Domm A; Zhang L; Shaikh M; Banan A; Fields JZ
    Am J Gastroenterol; 2005 Aug; 100(8):1796-804. PubMed ID: 16086717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
    Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
    J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypical characterization, distribution and quantification of different mast cell subtypes in transmural biopsies from the gastrointestinal tract of cats with inflammatory bowel disease.
    Kleinschmidt S; Harder J; Nolte I; Marsilio S; Hewicker-Trautwein M
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):190-200. PubMed ID: 20646765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
    Hahn HP; Hornick JL
    Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction.
    Demaude J; Salvador-Cartier C; Fioramonti J; Ferrier L; Bueno L
    Gut; 2006 May; 55(5):655-61. PubMed ID: 16299034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of colonoscopy premedication containing diazepam and pethidine on the release of mast cell mediators in gut mucosal samples.
    Raithel M; Hochberger J; Hahn EG
    Endoscopy; 1995 Aug; 27(6):415-23. PubMed ID: 8549437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases.
    Rijnierse A; Redegeld FA; Blokhuis BR; Van der Heijden MW; Te Velde AA; Pronk I; Hommes DW; Nijkamp FP; Koster AS; Kraneveld AD
    J Immunol; 2010 Jul; 185(1):653-9. PubMed ID: 20505143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of pericryptal fibroblasts correlates with density of distinct mast cell phenotypes in the crypt lamina propria of human duodenum: implications for the homeostasis of villous architecture.
    Crivellato E; Finato N; Isola M; Pandolfi M; Ribatti D; Beltrami CA
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Jun; 288(6):593-600. PubMed ID: 16652353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
    Caruso R; Fina D; Peluso I; Stolfi C; Fantini MC; Gioia V; Caprioli F; Del Vecchio Blanco G; Paoluzi OA; Macdonald TT; Pallone F; Monteleone G
    Gastroenterology; 2007 Jan; 132(1):166-75. PubMed ID: 17241869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.
    Jahanyar J; Youker KA; Torre-Amione G; Koerner MM; Bruckner B; Noon GP; Loebe M
    J Heart Lung Transplant; 2008 Jul; 27(7):701-9. PubMed ID: 18582797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline and stimulated turnover of cell surface c-Kit expression in different types of human mast cells.
    Babina M; Rex C; Guhl S; Thienemann F; Artuc M; Henz BM; Zuberbier T
    Exp Dermatol; 2006 Jul; 15(7):530-7. PubMed ID: 16761962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing.
    Huttunen M; Naukkarinen A; Horsmanheimo M; Harvima IT
    Arch Dermatol Res; 2002 Oct; 294(7):324-30. PubMed ID: 12373338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
    Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
    Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
    Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J
    Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
    Andoh A; Deguchi Y; Inatomi O; Yagi Y; Bamba S; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Jul; 16(1):103-7. PubMed ID: 16786130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural injury to interstitial cells of Cajal and communication with mast cells in Crohn's disease.
    Wang XY; Zarate N; Soderholm JD; Bourgeois JM; Liu LW; Huizinga JD
    Neurogastroenterol Motil; 2007 May; 19(5):349-64. PubMed ID: 17509017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional abnormalities in the intestine associated with mucosal mast cell activation.
    Crowe SE; Perdue MH
    Reg Immunol; 1992; 4(2):113-7. PubMed ID: 1503888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.